Adage Capital Partners’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,100,000
| Closed | -$8.13M | – | 902 |
|
|
2024
Q4 | $8.13M | Buy |
2,100,000
+399,123
| +23% | +$1.54M | 0.01% | 654 |
|
|
2024
Q3 | $11.1M | Buy |
1,700,877
+329,377
| +24% | +$2.16M | 0.02% | 587 |
|
|
2024
Q2 | $9.94M | Sell |
1,371,500
-61,953
| -4% | -$449K | 0.02% | 609 |
|
|
2024
Q1 | $10.9M | Buy |
1,433,453
+156,773
| +12% | +$1.19M | 0.02% | 581 |
|
|
2023
Q4 | $5.81M | Buy |
1,276,680
+100,000
| +8% | +$455K | 0.01% | 665 |
|
|
2023
Q3 | $4.65M | Buy |
1,176,680
+525,000
| +81% | +$2.07M | 0.01% | 674 |
|
|
2023
Q2 | $2.04M | Hold |
651,680
| – | – | ﹤0.01% | 739 |
|
|
2023
Q1 | $2.95M | Hold |
651,680
| – | – | 0.01% | 749 |
|
|
2022
Q4 | $2.69M | Hold |
651,680
| – | – | 0.01% | 796 |
|
|
2022
Q3 | $2.09M | Buy |
651,680
+475,000
| +269% | +$1.52M | 0.01% | 854 |
|
|
2022
Q2 | $346K | Hold |
176,680
| – | – | ﹤0.01% | 950 |
|
|
2022
Q1 | $716K | Hold |
176,680
| – | – | ﹤0.01% | 945 |
|
|
2021
Q4 | $1.91M | Hold |
176,680
| – | – | ﹤0.01% | 873 |
|
|
2021
Q3 | $2.04M | Buy |
176,680
+100,000
| +130% | +$1.15M | ﹤0.01% | 894 |
|
|
2021
Q2 | $753K | Buy |
+76,680
| New | +$753K | ﹤0.01% | 919 |
|